Ventricular Assist Devices Market Size

  • Report ID: 1410
  • Published Date: Jun 19, 2025
  • Report Format: PDF, PPT

Ventricular Assist Devices Market Outlook:

Ventricular Assist Devices Market size was valued at USD 2.77 billion in 2024 and is set to reach USD 8.91 billion by the end of 2037, expanding at around 9.4% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of ventricular assist devices is estimated at USD 2.98 billion.

In 2023, the worldwide pool for VADs mainly consists of patients with heart failure conditions at the end stage, undergoing destination therapy. The worldwide trade structure for the VAD components includes the assembly of pumps and sensors. The raw material supply chain includes titanium, electronic components such as batteries and sensors, and polymers. In the last few years, shortages of batteries and semiconductors have caused delays in the VAD production. To overcome this, companies are opening VAD production facilities to lower their dependency on other countries.

The government in the U.S. allocates funds for researching Ventricular Assist Devices (VADs) with the help of agencies such as the National Institutes of Health (NIH). These fundings help make it safer and effective for the patients. Ventricular assist devices market players have developed smaller and quieter VADs, operative for 10 years without replacement. Hospitals are conducting testing on 3D-printed VAD components customized to individual patients. More doctors are monitoring patients remotely to anticipate complications or any emergencies even before they happen. Healthcare practitioners are preferring smart VADs, which are AI-enabled and helpful in adjusting blood flow based on the patient's activity.


Ventricular Assist Devices Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Currently in 2025, the industry revenue of ventricular assist devices is evaluated at USD 2.98 billion.

The global ventricular assist devices market is set to rise from USD 2.77 billion in 2024 to USD 8.91 billion by 2037, witnessing a CAGR of more than 9.4% throughout the forecast period, between 2025 and 2037.

The North America region ventricular assist devices market is projected to register a remarkable revenue share of 45.5% between 2025 and 2037.

The major players in the market include Abbott Laboratories, Medtronic plc, Berlin Heart GmbH, Abiomed Inc. (Johnson & Johnson MedTech), Jarvik Heart Inc., Terumo Corporation, SynCardia Systems LLC, Evaheart Inc. and other.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos